Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-03

Clinical Trial Update: Evaluation of Long-term Buprenorphine Plasma Exposure

View source ↗

Summary

A completed clinical trial evaluating long-term buprenorphine plasma exposure in individuals with opioid-use disorder, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid-use Disorder | Status: COMPLETED | Results posted: 2020-08-03